HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
MENS - Jyong Biotech Ltd - Stock Price Chart
TickerMENS [NASD]
CompanyJyong Biotech Ltd
CountryTaiwan
IndustryBiotechnology
Market Cap589.39MEPS (ttm)-0.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own64.46%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume464.56K52W Range6.01 - 19.99
Jun-18-25 05:20PM Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering (GlobeNewswire) -20.87%
NTHI - NeOnc Technologies Holdings Inc - Stock Price Chart
TickerNTHI [NASD]
CompanyNeOnc Technologies Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap110.94MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-668.15%
Dividend-Sales Q/Q-
Insider Own79.15%Inst Own0.31%
Insider Trans0.16%Inst Trans0.09%
Short Float0.53%Earnings-
Analyst Recom-Target Price-
Avg Volume67.94K52W Range3.20 - 25.00
Jun-06-25 09:00AM NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs (GlobeNewswire)
Apr-15-25 08:05AM NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets (GlobeNewswire)
Apr-14-25 08:05AM NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September (GlobeNewswire) -12.06%
Apr-10-25 08:05AM NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President (GlobeNewswire) -10.00%
Apr-08-25 04:05PM NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy (GlobeNewswire)
Mar-31-25 08:05AM NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas (GlobeNewswire) -19.27%
Mar-28-25 11:15PM U.S. IPO Weekly Recap: CoreWeave Fails To Impress In Downsized IPO, As More Names Join The Pipeline (Seeking Alpha) +37.92%
Mar-27-25 08:05AM NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments (GlobeNewswire)
SY - So-Young International Inc ADR - Stock Price Chart
TickerSY [NASD]
CompanySo-Young International Inc ADR
CountryChina
IndustryHealth Information Services
Market Cap275.01MEPS (ttm)-0.82
P/E-EPS this Y88.43%
Forward P/E-EPS next Y56.12%
PEG-EPS past 5Y-
P/S1.37EPS next 5Y74.13%
P/B1.33EPS Q/Q-55.94%
Dividend0.03%Sales Q/Q-7.74%
Insider Own16.60%Inst Own8.57%
Insider Trans0.00%Inst Trans-36.28%
Short Float0.08%EarningsMay 16/b
Analyst Recom3.00Target Price0.80
Avg Volume808.25K52W Range0.64 - 3.60
Jul-03-25 05:00AM So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire)
Jun-20-25 05:00AM So-Young Announces Extension of Plan to Implement ADS Ratio Change (PR Newswire) +15.84%
May-30-25 05:00AM So-Young Announces Plan to Implement ADS Ratio Change (PR Newswire) -5.87%
May-17-25 03:03AM So-Young International Inc (SY) Q1 2025 Earnings Call Highlights: Aesthetic Treatment Surge ... (GuruFocus.com)
01:03AM Q1 2025 So-Young International Inc Earnings Call (Thomson Reuters StreetEvents)
May-16-25 06:36AM So-Young Reports Unaudited First Quarter 2025 Financial Results (PR Newswire)
May-06-25 05:00AM So-Young to Report First Quarter 2025 Financial Results on May 16, 2025 (PR Newswire)
Apr-21-25 04:26PM So-Young International Inc (SY) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Apr-18-25 07:10AM So-Young International Inc. Files Its Annual Report on Form 20-F (PR Newswire)
Apr-02-25 06:00AM So-Young International Inc. Announces Share Purchase by Controlling Shareholder (PR Newswire)
NCPL - Netcapital Inc - Stock Price Chart
TickerNCPL [NASD]
CompanyNetcapital Inc
CountryUSA
IndustryCapital Markets
Market Cap15.28MEPS (ttm)-16.99
P/E-EPS this Y102.72%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S18.86EPS next 5Y-
P/B0.40EPS Q/Q88.46%
Dividend-Sales Q/Q-85.36%
Insider Own1.81%Inst Own1.62%
Insider Trans0.00%Inst Trans0.69%
Short Float9.39%EarningsMar 17/a
Analyst Recom1.00Target Price2.25
Avg Volume342.01K52W Range1.41 - 11.90
Jul-03-25 08:00AM Netcapital Announces Up To $9.9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -20.71%
Jun-12-25 03:00PM Matt Morgan Joins Netcapital Crypto Advisory Board (GlobeNewswire) -12.42%
08:30AM Netcapital Announces Formation of Game Advisory Board (GlobeNewswire)
Jun-09-25 11:28AM Netcapital Portfolio Company Acquires Mixie (GlobeNewswire) +20.52%
Apr-23-25 08:30AM Netcapital Portfolio Company Acquires Spellbook Studio (GlobeNewswire)
Apr-17-25 08:30AM MAGFAST Raises More Than $10 Million Across Multiple Offerings on Netcapital (GlobeNewswire)
Apr-10-25 08:30AM Avadain Raises Over $1.275 Million in First 24 Hours on Netcapital (GlobeNewswire)
Mar-20-25 01:00PM Netcapital Inc (NCPL) Q3 2025 Earnings Call Highlights: Strategic Shift Amid Revenue Decline (GuruFocus.com) -7.53%
Mar-19-25 11:20AM Netcapital Inc. (NCPL) Q3 2025 Earnings Call Transcript (SeekingAlpha)
Mar-17-25 04:15PM Netcapital Announces Third Quarter Fiscal 2025 Financial Results (GlobeNewswire)
KNW - Know Labs Inc - Stock Price Chart
TickerKNW [AMEX]
CompanyKnow Labs Inc
CountryUSA
IndustryScientific & Technical Instruments
Market Cap18.37MEPS (ttm)-6.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y14.18%
P/S-EPS next 5Y-
P/B-EPS Q/Q53.95%
Dividend-Sales Q/Q-
Insider Own29.90%Inst Own0.46%
Insider Trans0.00%Inst Trans-59.86%
Short Float17.00%EarningsFeb 14/a
Analyst Recom1.00Target Price40.00
Avg Volume5.62M52W Range0.33 - 20.00
Jun-06-25 09:00AM Greg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury Strategy (Business Wire) +205.88%
Mar-19-25 09:00AM Know Labs Sensor Non-Invasively Identifies pH Levels in Real Time (Business Wire)
Mar-18-25 09:00AM Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) (Business Wire)
Jan-30-25 09:00AM Know Labs Responds to NYSE Commencement of Proceedings to Delist (Business Wire) -7.83%
Jan-21-25 05:00AM Know Labs Launches Know Labs Technology Licensing (KTL) (Business Wire) -9.53%
Dec-13-24 09:00AM Know Labs, Inc. Announces $300K Registered Direct Offering (Business Wire) -11.25%
Dec-11-24 09:00AM Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance (Business Wire) +12.16%
JEM - 707 Cayman Holdings Ltd - Stock Price Chart
TickerJEM [NASD]
Company707 Cayman Holdings Ltd
CountryHong Kong
IndustryApparel Retail
Market Cap107.77MEPS (ttm)0.05
P/E102.29EPS this Y17.10%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S9.54EPS next 5Y-
P/B70.14EPS Q/Q53.80%
Dividend-Sales Q/Q14.30%
Insider Own74.50%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.89%Earnings-
Analyst Recom-Target Price-
Avg Volume551.08K52W Range3.05 - 7.90
Jun-10-25 02:04PM 707 Cayman Holdings Limited Announces Closing of $10.0 Million Initial Public Offering (GlobeNewswire)
Jun-09-25 10:41AM 707 Cayman Holdings Limited Announces Pricing of $10.0 Million Initial Public Offering (GlobeNewswire)
BGLC - BioNexus Gene Lab Corp - Stock Price Chart
TickerBGLC [NASD]
CompanyBioNexus Gene Lab Corp
CountryMalaysia
IndustrySpecialty Chemicals
Market Cap11.55MEPS (ttm)-1.18
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-21.27%
P/S1.25EPS next 5Y-
P/B1.49EPS Q/Q-490.97%
Dividend-Sales Q/Q-10.28%
Insider Own34.65%Inst Own0.88%
Insider Trans0.00%Inst Trans-11.01%
Short Float1.36%Earnings-
Analyst Recom-Target Price-
Avg Volume1.50M52W Range2.01 - 15.60
Apr-30-25 11:25AM BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness (GlobeNewswire)
Apr-15-25 11:00AM BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory (GlobeNewswire) +14.22%
Mar-08-25 11:10AM Bionexus Gene Lab enters partnership with ML Tech (TipRanks)
Mar-07-25 11:00AM BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy (GlobeNewswire) +6.96%
Mar-05-25 11:00AM BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper (GlobeNewswire)
Sep-25-24 11:31AM BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. (GlobeNewswire)
Sep-13-24 12:05PM BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. (GlobeNewswire)
Sep-12-24 01:23PM BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions (GlobeNewswire) +8.36%
Sep-11-24 11:05AM BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production (GlobeNewswire)
Aug-27-24 11:35AM BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd (GlobeNewswire)
AYRO - AYRO Inc - Stock Price Chart
TickerAYRO [NASD]
CompanyAYRO Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap3.88MEPS (ttm)-17.73
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y55.68%
P/S388.00EPS next 5Y-
P/B1.27EPS Q/Q86.54%
Dividend-Sales Q/Q-100.00%
Insider Own21.94%Inst Own3.73%
Insider Trans0.00%Inst Trans-
Short Float8.57%Earnings-
Analyst Recom1.00Target Price40.00
Avg Volume23.31K52W Range5.17 - 15.28
Jun-24-25 09:15AM AYRO, Inc. Expands Strategic Alternatives Review to Include Digital Asset Strategies Focused on Stablecoin Technology (ACCESSWIRE)
May-07-25 10:42AM EV Company News For The Month Of April 2025 (Seeking Alpha)
Apr-04-25 02:02PM EV Company News For The Month Of March 2025 (Seeking Alpha) -7.55%
Feb-19-25 09:15AM AYRO Launches Robotics Division Focused on AI-Driven Automated Manufacturing of High Technology Vehicles and Support Products (ACCESSWIRE) -16.65%
Jan-16-25 09:15AM AYRO Highlights Recent Accomplishments and Updates Stakeholders on its Current Business Strategy (ACCESSWIRE)
Dec-16-24 09:15AM AYRO Secures Purchase Order From a Top Three Automotive Manufacturer (ACCESSWIRE) +5.90%
Dec-12-24 09:15AM AYRO Becomes Tier One Supplier for General Motors (ACCESSWIRE) -18.65%
Dec-04-24 09:15AM AYRO Partners with GLV Ventures for Lower Cost Engineering and Manufacturing Based in the United States (ACCESSWIRE)
Aug-21-24 09:00AM AYRO Appoints New Management Team to Re-Engineer and Revamp a Lower Cost Low-Speed Electric Vehicle (ACCESSWIRE)
Aug-15-24 10:52PM AYRO Stock Earnings: AYRO Reported Results for Q2 2024 (InvestorPlace) +8.86%
IROH - Iron Horse Acquisitions Corp - Stock Price Chart
TickerIROH [NASD]
CompanyIron Horse Acquisitions Corp
CountryUSA
IndustryShell Companies
Market Cap73.55MEPS (ttm)0.11
P/E74.57EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.08EPS Q/Q-82.40%
Dividend-Sales Q/Q-
Insider Own27.15%Inst Own73.40%
Insider Trans0.00%Inst Trans-
Short Float0.13%Earnings-
Analyst Recom-Target Price-
Avg Volume36.42K52W Range6.89 - 14.71
Jun-04-25 09:00AM Iron Horse Acquisitions Postpones Business Combination Special Meeting Until June 20, 2025 (Business Wire)
Oct-02-24 08:01AM Iron Horse Acquisitions Announces Business Combination Agreement With Parent of Zhong Guo Liang Tou Group Limited (D/B/A China Food Investment) (Business Wire)
SONN - Sonnet BioTherapeutics Holdings Inc - Stock Price Chart
TickerSONN [NASD]
CompanySonnet BioTherapeutics Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap12.41MEPS (ttm)-12.83
P/E-EPS this Y69.52%
Forward P/E-EPS next Y-
PEG-EPS past 5Y85.27%
P/S12.41EPS next 5Y-
P/B18.49EPS Q/Q-240.61%
Dividend-Sales Q/Q-
Insider Own1.22%Inst Own5.09%
Insider Trans0.00%Inst Trans74.16%
Short Float1.94%EarningsMay 20
Analyst Recom1.00Target Price20.00
Avg Volume2.24M52W Range1.08 - 10.02
May-01-25 09:00AM Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit (GlobeNewswire)
Apr-16-25 09:10AM Sonnet Releases Virtual Investor 'What This Means' Segment (GlobeNewswire)
Apr-04-25 09:00AM Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose (GlobeNewswire)
Apr-01-25 04:15PM Sonnet Announces Release of Corporate Update Video (GlobeNewswire) -5.22%
07:30AM Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D. (GlobeNewswire)
Mar-26-25 09:05AM Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas (GlobeNewswire)
Mar-19-25 08:50AM Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein (GlobeNewswire)
Mar-11-25 08:45AM Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor Top 5 for '25 On-Demand Conference (GlobeNewswire)
Feb-26-25 09:00AM Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors (GlobeNewswire)
Feb-19-25 08:35AM Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates (GlobeNewswire)
1234567⋯10⋯20
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.